[Pharmachem's salazopyrine in rheumatoid arthritis]

35 patients with classical form of rheumatoid arthritis were treated with Salazopyrin N "Pharmachim" prepared with the basic substance of the firm "AB-Uppsala"--Sweden. Side effects were seen in 9 patients and in 3 of them the treatment had to be discontinued. After a six months course of treatment remission was found in 18 patients (51%), in 8 patients (22.8%) the result was considered "good" with reduction of the inflammatory activity and in the remaining 5 patients there was little or no effect. The results coincide with those of other authors and support the data for the beneficial action of Salazopyrin N as a basic means in the treatment of rheumatoid arthritis. They also prove that the Bulgarian drug Salazopyrin N is of good quality and can be successfully used in the treatment of rheumatoid arthritis.